Corbus Pharmaceuticals Holdings (CRBP) Operating Leases (2018 - 2026)
Corbus Pharmaceuticals Holdings' Operating Leases was $307,000 in Q3 2025, down 85.0% from $2.05 million a year earlier and down 59.7% from the prior quarter.
Powered by 
Analysis
Corbus Pharmaceuticals Holdings (CRBP) Operating Leases (2018 - 2026) Analysis & Trends
At the end of FY2024, Operating Leases at Corbus Pharmaceuticals Holdings came in at $1.63 million, down 49.6% from FY2023.
- Operating Leases has now declined for five consecutive years, with a five-year compound annual growth rate of -27.4% (FY2019 to FY2024).
- In earlier years, Operating Leases was $3.24 million in FY2023 (-30.7%), $4.68 million in FY2022 (-21.5%), $5.96 million in FY2021 (-16.0%) and $7.09 million in FY2020 (-12.4%).
- The Q3 2025 figure marks the lowest quarterly Operating Leases in data going back to Q4 2018.
- Compared with a year earlier, Operating Leases has declined for 21 straight quarters, with an average decline of 51.0% over the last eight quarters.
- Over the past five years, the year-over-year decline in Operating Leases ranged from 12.4% (Q4 2020) to 85.0% (Q3 2025).
- Per Business Quant data, CRBP's Operating Leases in the three quarters before Q3 2025 was $761,000 (Q2 2025), $1.21 million (Q1 2025) and $1.63 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Corbus Pharmaceuticals Holdings | 80.98 Mn | -453.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.18 Mn |
| Jun 30, 2026 | 3.27 Mn |
| Mar 31, 2026 | 1.21 Mn |
| Sep 30, 2025 | 307,000.00 |
| Jun 30, 2025 | 761,000.00 |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Sep 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 2.86 Mn |
| Dec 31, 2023 | 3.24 Mn |
| Sep 30, 2023 | 3.61 Mn |
| Jun 30, 2023 | 3.98 Mn |
| Mar 31, 2023 | 4.33 Mn |
| Dec 31, 2022 | 4.68 Mn |
| Sep 30, 2022 | 5.01 Mn |
| Jun 30, 2022 | 5.33 Mn |
| Mar 31, 2022 | 5.65 Mn |
| Dec 31, 2021 | 5.96 Mn |
| Sep 30, 2021 | 6.25 Mn |
API Access
Corbus Pharmaceuticals Holdings Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=CRBP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "CRBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=CRBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();